Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.880
+0.030 (0.78%)
Dec 9, 2025, 4:00 PM EST - Market closed
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $43.4 million as of December 10, 2025. Its market cap has increased by 36.86% in one year.
Market Cap
43.40M
Enterprise Value
31.13M
1-Year Change
36.86%
Ranking
Category
Stock Price
$3.88
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $43.40M, an increase of 43.08%. That is a compound annual growth rate of 6.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 43.06M | 25.16% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |